Literature DB >> 4027881

Second malignancies in hairy cell leukemia.

R H Jacobs, E E Vokes, H M Golomb.   

Abstract

Among 172 patients with hairy cell leukemia (HCL) seen at the University of Chicago over a 10-year period, 15 were found to have a second malignancy. Neoplasia of the skin was noted most frequently; there were three cases of basal cell carcinoma, one case of anaplastic squamous cell carcinoma, and one case of malignant melanoma. This was followed in frequency by three cases of carcinoma of the lung. The clinical characteristics of these 15 patients did not differ from those of the general population of patients with HCL. A variety of second hematologic malignant disorders and solid tumors were identified. In one case, the second neoplasm occurred before the diagnosis of HCL; six were diagnosed concurrently; and eight followed the diagnosis of HCL. Since HCL is a well-defined clinicopathologic entity, patients with HCL who exhibit unusual features of the disease should be investigated further for the presence of second malignancies.

Entities:  

Mesh:

Year:  1985        PMID: 4027881     DOI: 10.1002/1097-0142(19850915)56:6<1462::aid-cncr2820560639>3.0.co;2-6

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  Coexistence between renal cell cancer and Hodgkin's lymphoma: a rare coincidence.

Authors:  Victor H Jimenez
Journal:  BMC Urol       Date:  2006-03-20       Impact factor: 2.264

2.  Synchronous occurrence of neuroendocrine colon carcinoma and hairy cell leukemia.

Authors:  Nikolaos S Salemis; Dionisios Pinialidis; Evangelos Tsiambas; Christos Gakis; Georgios Nakos; Dimitrios Sambaziotis; Charalambos Christofyllakis
Journal:  J Gastrointest Cancer       Date:  2011-09

3.  Skeletal involvement in hairy cell leukemia.

Authors:  C J Herold; G R Wittich; I Schwarzinger; J Haller; A Chott; G Mostbeck; P C Hajek
Journal:  Skeletal Radiol       Date:  1988       Impact factor: 2.199

4.  Case report 410: Hairy cell leukemia infiltrating the femora.

Authors:  C Peterson; P A Kaplan; K M Lorenzen
Journal:  Skeletal Radiol       Date:  1987       Impact factor: 2.199

5.  Durable response but prolonged cytopenia after cladribine treatment in relapsed patients with indolent non-Hodgkin's lymphomas: results of a Japanese phase II study.

Authors:  Michinori Ogura; Yasuo Morishima; Yukio Kobayashi; Naokuni Uike; Susumu Sugai; Takaaki Chou; Masaharu Kasai; Ikuo Miura; Tohru Murayama; Yoshihiro Matsuno; Shigeo Nakamura; Shigeo Mori; Yasuo Ohashi; Kensei Tobinai
Journal:  Int J Hematol       Date:  2004-10       Impact factor: 2.490

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.